ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $1.29M invested in Entero Therapeutics in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$130K
2
+$90K

Top Sellers

1
-$161K
2
-$125K
3
-$37K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$24K
5
AAP
Ardsley Advisory Partners
Connecticut
-$17K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$623K
2
$161K
3
$130K
4
$90K
5
$63K
6
$57K
7
$39K
8
$36K
9
$27K
10
$21K
11
$14K
12
$14K
13
$14K
14
$1K
15
–
16
–
17
–
18
–
19
–